METYRAPONE AND PYROGEN IN THE ASSESSMENT OF PITUITARY-ADRENAL FUNCTION AFTER REMOVAL OF PITUITARY ADENOMA.
D015065:17-Hydroxycorticosteroids; D000236:Adenoma; D000324:Adrenocorticotropic Hormone; D001769:Blood; D007018:Hypopituitarism; D007659:Ketones; D008797:Metyrapone; D000451:Mineralocorticoid Receptor Antagonists; D010902:Pituitary Gland; D010910:Pituitary Irradiation; D010911:Pituitary Neoplasms; D010912:Pituitary-Adrenal Function Tests; D011749:Pyrogens; D013223:Statistics as Topic; D013514:Surgical Procedures, Operative
D015065:17-Hydroxycorticosteroids; D007659:Ketones; D000451:Mineralocorticoid Receptor Antagonists; D011749:Pyrogens; D000324:Adrenocorticotropic Hormone; D008797:Metyrapone
17-HYDROXYCORTICOSTEROIDS; ALDOSTERONE ANTAGONISTS; BLOOD; CORTICOTROPIN; HYPOPITUITARISM; KETONES; METYRAPONE; PITUITARY GLAND; PITUITARY GLAND IRRADIATION; PITUITARY NEOPLASMS; PITUITARY-ADRENAL FUNCTION TESTS; PYROGENS; STATISTICS; SURGERY, OPERATIVE